Shares of Vera Therapeutics (VERA) sold off about 20% on Friday following news in competitor Otsuka’s 2024 earnings presentation that the ...
Q4 2024 Earnings Conference Call February 18, 2025 8:00 AM ETCompany ParticipantsMike Gianoni - President, Chief ...
MarketBeat on MSN19h
Analysts See Buying Opportunity in NVIDIA Before EarningsAnalysts say NVIDIA (NASDAQ: NVDA) is a buy ahead of earnings because the results will be robust, high-double-digit growth is ...
Evercore ISI analyst David Palmer is adding Wendy’s (WEN) to the firm’s “Tactical Outperform List” as the firm sees upside heading into Wendy’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback